| Financial Year |
March 31 2023 |
| Monetary Funds |
888,558,844.96 |
| Held-for-trading Financial Assets |
456,033,326.80 |
| Notes Receivable |
114,889,338.75 |
| Accounts Receivable |
507,024,626.00 |
| Advances to Suppliers |
11,744,291.65 |
| Other Receivables |
1,789,992.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
348,430,280.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,028,635.75 |
| Total Current Assets |
2,416,292,905.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
31,750,044.82 |
| Fixed Assetes |
217,720,696.63 |
| Under-construction Projects |
75,568,914.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,748,135.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
13,856,719.21 |
| Other Non-Current Assets |
85,630,779.78 |
| Sub-Total of Non-Current Assets |
502,249,930.72 |
| Total Assets |
2,918,542,836.21 |
| Short-Term Loans |
19,821,958.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
548,008,822.95 |
| Accounts Payable |
287,579,137.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,253,321.39 |
| Taxes Payable |
6,016,581.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
971,050.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
490,301.82 |
| Other Current Liabilities |
42,141.33 |
| Sub-Total of Current Liabilities |
897,008,521.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
920,298.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
37,876,625.23 |
| Total Liabilities |
934,885,147.13 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
1,072,883,881.69 |
| Surplus Reserve |
71,394,857.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
719,378,950.07 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,983,657,689.08 |
| Owner's Equity（Stockholder's Equity） |
1,983,657,689.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,918,542,836.21 |
